. | Mean Fura-2 signal from line-scan analysis . | . | . | |
---|---|---|---|---|
Treatment . | Right . | Left . | Ratio of left/right Cai2+ enrichment . | |
Untreated | 171.1±9.4 (3) | 186.6±12.2 | 2.55±0.21 (3) | |
Fluoxetine, 10 μM | 143.5±23.0 (11)* | 158.3±17.7** | 1.38±0.13 (6)** | |
2-Methyl-5HT, 25 μM | 135.0±21.8 (11)** | 153.6±17.6** | 0.52±0.26 (4)** | |
Ondansetron, 25 μM | 188.4±19.2 (10)* | 200.5±8.7* | 0.97±0.25 (6)** | |
ML 10302, 25 μM | 119.8±18.8 (9)** | 130.2±25.5** | 0.82±0.08 (6)** | |
GR 125487, 25 μM | 188.3±10.8 (10)** | 195.4±10.9 | 1.03±0.05 (10)** | |
Concanamycin, 100 nM | 151.2±13.7 (13)** | 150.8±13.6** | 1.04±0.24 (6)** | |
Lansoprozole, 7 μM | 186.1±13.7 (14)** | 183.8±18.1 | 1.03±0.19 (7)** |
. | Mean Fura-2 signal from line-scan analysis . | . | . | |
---|---|---|---|---|
Treatment . | Right . | Left . | Ratio of left/right Cai2+ enrichment . | |
Untreated | 171.1±9.4 (3) | 186.6±12.2 | 2.55±0.21 (3) | |
Fluoxetine, 10 μM | 143.5±23.0 (11)* | 158.3±17.7** | 1.38±0.13 (6)** | |
2-Methyl-5HT, 25 μM | 135.0±21.8 (11)** | 153.6±17.6** | 0.52±0.26 (4)** | |
Ondansetron, 25 μM | 188.4±19.2 (10)* | 200.5±8.7* | 0.97±0.25 (6)** | |
ML 10302, 25 μM | 119.8±18.8 (9)** | 130.2±25.5** | 0.82±0.08 (6)** | |
GR 125487, 25 μM | 188.3±10.8 (10)** | 195.4±10.9 | 1.03±0.05 (10)** | |
Concanamycin, 100 nM | 151.2±13.7 (13)** | 150.8±13.6** | 1.04±0.24 (6)** | |
Lansoprozole, 7 μM | 186.1±13.7 (14)** | 183.8±18.1 | 1.03±0.19 (7)** |
Left and right mean Fura-2 signal, relative Cai2+levels and the LR Cai2+ ratio were calculated as described in the Materials and methods. The number of embryos analyzed is indicated in parentheses. Asterisks indicate that values differ from HH6 controls on that side at *P<0.05 and **P<0.005 using an unpaired t-test.